Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB571 in Advanced or Metastatic Pancreatic Cancer
NCT07814066Phase 2Not yet recruiting
- Sponsor
- Kelun-Biotech
- Start
- Oct 2026
- Primary completion
- Feb 2028
01
Overview
A Phase 2 trial of SKB571 in pancreatic cancer (PC), sponsored by Kelun-Biotech. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
SKB571
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07814066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814066.